Results 1 to 10 of about 12,383 (214)

Update on eosinophilic granulomatosis with polyangiitis

open access: yesAllergology International, 2019
Eosinophilic granulomatosis with polyangiitis (EGPA) (formerly Churg-Strauss syndrome) is a rare form of anti-neutrophil cytoplasm antibody (ANCA)-associated vasculitis characterized by eosinophil-rich granulomatous inflammation and small to medium-size ...
Shunsuke Furuta   +2 more
doaj   +4 more sources

Eosinophilic granulomatosis with polyangiitis: A review

open access: yesAutoimmunity Reviews, 2023
Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare, multi-system, inflammatory disease, belonging to the group of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAV). Previously known as Churg-Strauss syndrome, EGPA is characterised by late-onset asthma, eosinophilia and vasculitis affecting small-to-medium vessels ...
Jpe, White, S, Dubey
openaire   +3 more sources

Cardiac Involvement in Eosinophilic Granulomatosis with Polyangiitis. [PDF]

open access: yesCurr Cardiol Rep
This review highlights recent advances in the pathophysiology, diagnosis, and treatment of cardiac disease in patients with Eosinophilic granulomatosis with polyangiitis (EGPA).
Srikantharajah M   +5 more
europepmc   +2 more sources

Mepolizumab or placebo for eosinophilic granulomatosis with polyangiitis [PDF]

open access: yesNew England Journal of Medicine, 2017
Background Eosinophilic granulomatosis with polyangiitis is an eosinophilic vasculitis. Mepolizumab, an anti–interleukin-5 monoclonal antibody, reduces blood eosinophil counts and may have value in the treatment of eosinophilic granulomatosis with ...
Akuthota, Praveen   +58 more
core   +3 more sources

Potential masking of new-onset or relapsed eosinophilic granulomatosis with polyangiitis during benralizumab treatment: A case series

open access: yesJournal of Allergy and Clinical Immunology: Global
Eosinophilic granulomatosis with polyangiitis can manifest without eosinophilia and eosinophilic infiltration during benralizumab treatment, emphasizing the need for clinical vigilance beyond eosinophil counts.
Shin-ichiro Ohmura, MD, PhD   +2 more
doaj   +2 more sources

Eosinophilic Cholecystitis Associated with Eosinophilic Granulomatosis with Polyangiitis [PDF]

open access: yesCase Reports in Gastroenterology, 2020
We report a case of eosinophilic cholecystitis associated with eosinophilic granulomatosis with polyangiitis (EGPA) complicated by cerebral hemorrhage.
Hiroyuki Ito   +13 more
doaj   +3 more sources

Eosinophilic granulomatosis with polyangiitis: an overview [PDF]

open access: yesFrontiers in Immunology, 2014
Eosinophilic granulomatosis with polyangiitis (EGPA) is a multisystemic disorder, belonging to the small vessel ANCA-associated vasculitis, defined as a eosinophil-rich and necrotizing granulomatous inflammation often involving the respiratory tract, and
Andrea eGioffredi   +3 more
doaj   +3 more sources

A presentation of recurrent cerebral ischemic stroke in eosinophilic granulomatosis with polyangiitis: a case report. [PDF]

open access: yesJ Med Case Rep
Background Eosinophilic granulomatosis with polyangiitis is characterized as a small vessel vasculitis with the propensity to have a myriad of presentations due to the targeting of several different organ systems. More often than not, it is the pulmonary
Gregory B   +6 more
europepmc   +2 more sources

An overlap of granulomatosis with polyangiitis and eosinophilic granulomatosis with polyangiitis

open access: yesSaudi Journal of Kidney Diseases and Transplantation, 2017
We present a case report of overlap of granulomatosis with polyangiitis (GPA; formerly known as Wegener’s granulomatosis) and eosinophilic granulomatosis with polyangiitis (EGPA; formerly known as Churg-Strauss syndrome).
Sujit Surendran   +4 more
doaj   +3 more sources

Benralizumab for eosinophilic granulomatosis with polyangiitis

open access: yesAnnals of the Rheumatic Diseases, 2023
Benralizumab is effective in the treatment of eosinophilic asthma and is being investigated for the treatment of other eosinophil-associated diseases. Reports on the use of benralizumab for the treatment of eosinophilic granulomatosis with polyangiitis (EGPA) are limited to case reports and small case series.We conducted a multicentre, retrospective ...
Cottu, Adrien   +26 more
openaire   +4 more sources

Home - About - Disclaimer - Privacy